Compare IPSC & DSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPSC | DSC |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.1M | 293.4M |
| IPO Year | 2021 | 2023 |
| Metric | IPSC | DSC |
|---|---|---|
| Price | $1.69 | $2.69 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.75 | N/A |
| AVG Volume (30 Days) | ★ 968.6K | 20.4K |
| Earning Date | 11-20-2026 | 12-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $15.21 |
| Revenue Next Year | N/A | $56.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $2.96 |
| 52 Week High | $2.97 | $9.60 |
| Indicator | IPSC | DSC |
|---|---|---|
| Relative Strength Index (RSI) | 55.34 | 26.39 |
| Support Level | $1.29 | N/A |
| Resistance Level | $1.75 | $3.77 |
| Average True Range (ATR) | 0.16 | 0.36 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 73.75 | 8.43 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
DSC Holdings Ltd is an AI application infrastructure for China's used car industry. According to CIC, the Company has held over 90% market share in operating systems for China's used car dealers, giving it nationwide dealer connections and massive, granular, proprietary, real-time industry data. Building on this digital foundation, the group further supports used car dealers with essential transaction services across their workflows. Its Services engage and benefit thousands of dealer collaborators, such as inspectors, transporters, and other internet platforms, creating an ecosystem with used car dealers at its center.